A research-grade profile of HGH fragment 176-191 and its tyrosine-modified analogue AOD-9604, covering structure, lipolytic mechanism, beta-3 adrenoceptor pharmacology, the Monash/Metabolic Pharmaceuticals clinical lineage, and comparison with incretin-based metabolic peptides.